Proceedings of the National Academy of Sciences · 1979 · 730 citations · 24 references
MedicineCancer BiologyOncologyCarcinogenesisMolecular OncologyOncogenesOncogenic VirusesTumor AntigensTumor-associated AntigensP53 AbnormalityViral EtiologyViral Tumor Antigens
Antisera prepared against BALB/c Meth A sarcoma in syngeneic or compatible F1 mice recognize a protein with an apparent molecular weight of 53,000 in extracts of [35S]methionine-labeled transformed BALB/c cells. This component, designated p53, was not detected in normal adult mouse fibroblasts, lymphoid cells, or hematopoietic cells or in mouse embryo cells or 3T3 cells. An extensive variety of antisera, including alloantisera and heterologous antisera directed against structural antigens of murine leukemia viruses, was tested for reactivity with p53; other than Meth A antisera, only comparably prepared antisera against another BALB/c sarcoma, CMS4, had anti-p53 activity. All transformed mouse cells tested were found to express p53; these tests included chemically induced sarcomas, leukemias, spontaneously transformed fibroblasts, and cells transformed by simian virus 40 and murine sarcoma virus. The presence of p53 in tumors of no known viral etiology indicates coding by resident cellular genes; this does not exclude endogenous viruses as the source of coding sequences or the possibility that transforming viruses code directly for p53.
24
Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin.
Foley Ej · PubMed · 1953 · 690 citations
Medicine, Immunology, Oncology +14